Association of androgen‐deprivation therapy with excess cardiac‐specific mortality in men with prostate cancer

Abstract

ADT was associated with a 5% absolute excess risk of CSM at 5 years in men with CHF or prior MI, suggesting that administering ADT to 20 men in this potentially vulnerable subgroup could result in one cardiac death.